Localization of the Ankyrin-binding Site on Erythrocyte Membrane Protein, Band 3

• Published in: The Journal of biological chemistry Vol. 264; no. 27; pp. 15893 - 15899
• Main Authors: Willardson, B M, Thevenin, B J M, Harrison, M L, Kuster, W M, Benson, M D, Low, P S
• Format: Journal Article
• Language: English
• Published: Bethesda, MD Elsevier Inc 25.09.1989; American Society for Biochemistry and Molecular Biology
• Subjects: Amino Acid Sequence; Analytical, structural and metabolic biochemistry; Anion Exchange Protein 1, Erythrocyte - chemical synthesis; Anion Exchange Protein 1, Erythrocyte - immunology; Anion Exchange Protein 1, Erythrocyte - metabolism; Ankyrins; Antibodies, Monoclonal; Binding and carrier proteins; Binding Sites; Biological and medical sciences; Blood Proteins - metabolism; Epitopes - analysis; Erythrocyte Membrane - metabolism; erythrocytes; Fundamental and applied biological sciences. Psychology; Kinetics; membrane proteins; Membrane Proteins - metabolism; Models, Structural; Molecular Sequence Data; Peptides - chemical synthesis; Proteins; Band 3 protein
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1016/S0021-9258(18)71562-7

The predominant attachment site of the spectrinbased cytoskeleton to the erythrocyte membrane occurs via the interaction of ankyrin with the cytoplasmic domain of band 3 (cdb3). In order to further characterize this interaction, we have conducted experiments to localize the ankyrin-binding site on cdb3. Four monoclonal and three antipeptide polyclonal antibodies were raised against cdb3 and used in competition studies to identify regions of close association of cdb3 with ankyrin. Antibodies to regions of cdb3 near the cytoplasmic domain-membrane spanning domain junction had no effect on 125I-ankyrin binding. Likewise, an antibody to a highly conserved region between residues 142 and 154 did not inhibit ankyrin binding. However, antibodies at or near the cysteine 201–317 cluster and the proposed proline-rich hinge in the center of cdb3 were potent inhibitors of ankyrin association, as were antibodies to the acidic NH2 terminus. Additional evidence for interaction of ankyrin with the NH2-terminal region of cdb3 was obtained by demonstrating the ability of ankyrin to inhibit tyrosine phosphorylation of cdb3 at its NH2 terminus by a purified calf thymus tyrosine kinase. These studies reveal two regions of cdb3, distant in primary sequence, which interact with ankyrin. A specific conformation of cdb3 may be required to permit these regions to simultaneously associate with ankyrin and allow binding to occur.